Alignment Healthcare, Inc. (NASDAQ:ALHC – Get Rating)’s stock price gapped down before the market opened on Wednesday . The stock had previously closed at $9.94, but opened at $8.50. Alignment Healthcare shares last traded at $8.83, with a volume of 388,534 shares trading hands.
Wall Street Analysts Forecast Growth
Several research firms have recently commented on ALHC. Raymond James lowered Alignment Healthcare from an “outperform” rating to a “market perform” rating in a report on Monday, November 21st. TD Cowen reduced their price objective on Alignment Healthcare from $17.00 to $10.00 and set an “outperform” rating for the company in a research report on Thursday. Finally, JPMorgan Chase & Co. downgraded Alignment Healthcare from an “overweight” rating to a “neutral” rating and reduced their price objective for the stock from $22.00 to $12.00 in a research report on Thursday, February 23rd. Three equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $16.91.
Alignment Healthcare Price Performance
The stock has a market capitalization of $1.39 billion, a price-to-earnings ratio of -9.02 and a beta of 1.86. The company has a quick ratio of 2.03, a current ratio of 2.03 and a debt-to-equity ratio of 0.59. The business has a 50-day simple moving average of $11.25 and a two-hundred day simple moving average of $12.42.
Insiders Place Their Bets
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of ALHC. Durable Capital Partners LP raised its stake in Alignment Healthcare by 2,079.2% during the 1st quarter. Durable Capital Partners LP now owns 5,908,220 shares of the company’s stock valued at $66,349,000 after purchasing an additional 5,637,102 shares during the period. Marshall Wace LLP acquired a new stake in Alignment Healthcare during the 3rd quarter valued at $34,129,000. Vanguard Group Inc. raised its stake in Alignment Healthcare by 25.1% during the 3rd quarter. Vanguard Group Inc. now owns 8,117,393 shares of the company’s stock valued at $96,111,000 after purchasing an additional 1,626,831 shares during the period. T. Rowe Price Investment Management Inc. raised its stake in Alignment Healthcare by 15.1% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 8,470,181 shares of the company’s stock valued at $99,610,000 after purchasing an additional 1,108,973 shares during the period. Finally, BlackRock Inc. raised its stake in Alignment Healthcare by 21.8% during the 3rd quarter. BlackRock Inc. now owns 5,698,621 shares of the company’s stock valued at $67,471,000 after purchasing an additional 1,020,637 shares during the period. Institutional investors own 83.49% of the company’s stock.
About Alignment Healthcare
Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantage plans in the states of California, North Carolina, Nevada, and Arizona.
- Get a free copy of the StockNews.com research report on Alignment Healthcare (ALHC)
- Hormel Hits 2-Year Low, And The Dip Gets Bought
- Here’s Why Ross Could Soon Be Hitting All Time Highs
- The Bottom Is In For Salesforce.com
- It’s Time For A Fresh Look At The Kroger Co.
- West Fraser’s Earnings Scream Timber, Outlook Says Buy
Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.